| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Comm. Officer
1 company
McNeely Theresa is an EVP, Chief Comm. Officer at Tempest Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $796 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2015 | TPST Tempest Therapeutics, Inc. | EVP, Chief Comm. Officer | Buy | 400 | $29.29 | $11,717.14 | +229.9% |